RxDoctor Payments DataLook up a doctor →

James Reeves

Medical Oncology · Fort Myers, FLNPI 1447233986

Payments from drug & device makers

$7,098,633in general payments, 2019–2025

Across 1,064 payments — averaging $6671.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$995K
  • Merck$953K
  • Eli Lilly$900K
  • E.r. Squibb & Sons, L.L.C.$825K
  • Genentech, Inc.$608K
  • Sanofi US Services Inc.$544K
  • plus $2.3M from 53 others
$19,261in research payments, 2019–2025

Across 7 payments — averaging $2751.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$17K
  • F. Hoffmann-la Roche AG$2K
  • Bristol Myers Squibb$403
  • Takeda Pharmaceuticals U.S.A., Inc.$67

What the payments were for

  • Consulting fees$1210%
  • Speaking & faculty fees$27,52869%
  • Travel & lodging$2,6117%
  • Food & beverage$9,02823%
  • Education$8062%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca107$994,619
Merck112$952,522
Eli Lilly21$899,991
E.r. Squibb & Sons, L.L.C.31$825,335
Genentech, Inc.95$608,312
Sanofi US Services Inc.72$543,665
TG Therapeutics, Inc.184$441,344
Astrazeneca UK Limited18$330,738
Clovis Oncology, Inc.38$319,642
Bristol Myers Squibb17$265,572
Acerta Pharma LLC18$254,678
Takeda Pharmaceuticals U.S.A., Inc.71$206,241
Tesaro, Inc.22$135,120
Roche Products Limited7$102,356
Pfizer32$65,875
GSK12$51,241
Seagen Inc.46$47,357
Eisai Inc.22$18,100
Johnson & Johnson16$12,512
Novocure Inc.12$9,328
Novartis8$8,320
Sanofi13$788
Exelixis Inc.7$567
Daiichi Sankyo Inc.8$459
W. L. Gore & Associates, Inc.3$436
Foundation Medicine, Inc.3$354
Pharmacyclics LLC, An Abbvie Company3$283
Genentech USA, Inc.6$247
Adaptive Biotechnologies Corporation2$219
Epizyme, Inc.2$212
Jazz Pharmaceuticals Inc.2$197
Amgen6$157
Incyte Corporation5$157
Dendreon Pharmaceuticals LLC2$142
Puma Biotechnology, Inc.2$134
Verastem, Inc.2$127
Acrotech Biopharma Inc.1$121
Nanostring Technologies, Inc.3$116
AbbVie2$115
ADC Therapeutics America, Inc.1$105
Bayer2$101
EMD Serono, Inc.1$100
Array Biopharma Inc2$98
Sirtex Medical Inc1$94
Rigel Pharmaceuticals, Inc.1$91
Veracyte, Inc.6$59
Lilly USA, LLC2$44
Beigene USA, Inc.3$44
Karyopharm Therapeutics Inc.2$32
Dova Pharmaceuticals1$31
Heron Therapeutics, Inc.1$23
Gilead1$18
Lightforce Orthodontics, Inc.1$16
Aurobindo Pharma USA, Inc.1$13
Helsinn Therapeutics (U.S.), Inc.1$13
Spectrum Pharmaceuticals Inc.1$13
Blueprint Medicines Corporation1$13
Astellas Pharma US Inc1$13
Octapharma USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,098,633 in reported general payments places this provider in the 95th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Other medical oncology in Fort Myers

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →